Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry

by Sylvia Haas, Hugo Ten Cate, Gabriele Accetta, Pantep Angchaisuksiri, Jean Pierre Bassand, A. John Camm, Ramon Corbalan, Harald Darius, David A. Fitzmaurice, Samuel Z. Goldhaber, Shinya Goto, Barry Jacobson, Gloria Kayani, Lorenzo G. Mantovani, Frank Misselwitz, Karen Pieper, Sebastian M. Schellong, Janina Stepinska, Alexander G.G. Turpie, Martin Van Eickels, Ajay K. Kakkar
Published 2018

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

by Sylvia Haas, A. John Camm, Jean Pierre Bassand, Pantep Angchaisuksiri, Frank Cools, Ramon Corbalan, Harry Gibbs, Barry Jacobson, Yukihiro Koretsune, Lorenzo G. Mantovani, Frank Misselwitz, Elizaveta Panchenko, Hany Ibrahim Ragy, Janina Stepinska, Alexander GG Turpie, Jitendra PS Sawhney, Jan Steffel, Toon Wei Lim, Karen S. Pieper, Saverio Virdone, Freek WA Verheugt, Ajay K. Kakkar
Published 2020